🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
144,67 USD
Máx. histórico
156,45
70 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-7,53%
Rango 52 semanas
82,01 – 156,92
Variación hoy
-2,49%
Cierre anterior
148,36
Rango de hoy
143,47 – 147,62
Volumen hoy
8.862.415
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,42%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 146,13 (puede no estar actualizado)
- Dividend yield
- 2,29% (puede no estar actualizado)
- Precio objetivo analistas
- 160,29 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/03/1973 | 2,47 | 2,57 | 2,47 | 2,57 | +4,44% | 4,30% | 1.652.486 |
| 05/03/1973 | 2,45 | 2,48 | 2,43 | 2,46 | +0,40% | 2,16% | 977.155 |
| 02/03/1973 | 2,41 | 2,45 | 2,29 | 2,45 | +1,93% | 6,89% | 2.052.403 |
| 01/03/1973 | 2,45 | 2,49 | 2,41 | 2,41 | -1,89% | 3,51% | 569.693 |
| 28/02/1973 | 2,47 | 2,47 | 2,43 | 2,45 | -1,59% | 1,34% | 769.651 |
| 27/02/1973 | 2,50 | 2,52 | 2,47 | 2,49 | -0,40% | 1,85% | 792.288 |
| 26/02/1973 | 2,52 | 2,52 | 2,46 | 2,50 | -2,20% | 2,63% | 916.790 |
| 23/02/1973 | 2,57 | 2,59 | 2,55 | 2,56 | -0,51% | 1,54% | 509.328 |
| 22/02/1973 | 2,56 | 2,59 | 2,55 | 2,57 | +0,26% | 1,68% | 1.343.117 |
| 21/02/1973 | 2,59 | 2,59 | 2,56 | 2,56 | -1,15% | 0,90% | 780.970 |
| 20/02/1973 | 2,56 | 2,59 | 2,55 | 2,59 | +1,42% | 1,55% | 509.328 |
| 16/02/1973 | 2,56 | 2,58 | 2,56 | 2,56 | -0,26% | 0,90% | 430.099 |
| 15/02/1973 | 2,56 | 2,58 | 2,56 | 2,56 | +0,26% | 0,78% | 547.056 |
| 14/02/1973 | 2,59 | 2,59 | 2,55 | 2,56 | -1,15% | 1,41% | 962.064 |
| 13/02/1973 | 2,56 | 2,61 | 2,56 | 2,59 | +2,09% | 1,94% | 1.116.749 |
| 12/02/1973 | 2,51 | 2,55 | 2,50 | 2,53 | +0,92% | 1,85% | 969.610 |
| 09/02/1973 | 2,48 | 2,51 | 2,48 | 2,51 | +2,02% | 1,34% | 1.158.250 |
| 08/02/1973 | 2,47 | 2,47 | 2,44 | 2,46 | -0,27% | 0,94% | 833.789 |
| 07/02/1973 | 2,46 | 2,48 | 2,46 | 2,47 | +0,67% | 0,94% | 1.558.166 |
| 06/02/1973 | 2,43 | 2,47 | 2,42 | 2,45 | +0,82% | 1,77% | 1.343.117 |
| 05/02/1973 | 2,39 | 2,43 | 2,39 | 2,43 | +1,95% | 1,95% | 1.229.933 |
| 02/02/1973 | 2,44 | 2,44 | 2,39 | 2,39 | -2,17% | 2,31% | 2.063.722 |
| 01/02/1973 | 2,49 | 2,50 | 2,42 | 2,44 | -2,13% | 3,33% | 977.155 |
| 31/01/1973 | 2,50 | 2,51 | 2,49 | 2,49 | -0,40% | 0,80% | 845.107 |
| 30/01/1973 | 2,48 | 2,52 | 2,48 | 2,50 | +0,80% | 1,60% | 1.082.794 |
| 29/01/1973 | 2,52 | 2,52 | 2,48 | 2,48 | -1,96% | 1,71% | 728.150 |
| 26/01/1973 | 2,52 | 2,54 | 2,50 | 2,53 | +0,53% | 1,31% | 1.497.802 |
| 24/01/1973 | 2,55 | 2,55 | 2,50 | 2,52 | -1,56% | 1,82% | 531.965 |
| 23/01/1973 | 2,59 | 2,61 | 2,54 | 2,56 | -1,28% | 2,56% | 796.061 |
| 22/01/1973 | 2,57 | 2,60 | 2,56 | 2,59 | +0,77% | 1,29% | 505.555 |